Filtros de búsqueda

Lista de obras de Roberto Ferrara

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations

artículo científico publicado en 2016

Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report.

artículo científico publicado en 2015

Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study

scientific article published on 24 January 2019

An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer

artículo científico

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter

scientific article published on 04 December 2018

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.

artículo científico publicado en 2018

Atypical patterns of response and progression in the era of immunotherapy combinations

artículo científico publicado en 2020

Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy

scientific article published on 24 July 2019

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

artículo científico publicado en 2019

Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients

scientific article published on 14 January 2019

Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer.

artículo científico publicado en 2017

Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.

artículo científico publicado en 2016

Do immune checkpoint inhibitors need new studies methodology?

artículo científico publicado en 2018

Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer

scientific article published on 10 September 2019

Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In Reply

artículo científico publicado en 2019

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

scientific article published on 01 November 2018

Hyperprogressive disease: recognizing a novel pattern to improve patient management

scientific article published on 01 December 2018

Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?

artículo científico publicado en 2015

Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?

artículo científico publicado en 2017

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

scientific article published on 20 August 2018

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

artículo científico publicado en 2016

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

artículo científico publicado en 2019

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

scientific article published on 16 February 2019

Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer

artículo científico publicado en 2018

Progress in the Management of Advanced Thoracic Malignancies in 2017.

artículo científico publicado en 2018

Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?

scientific article published on 01 March 2019

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

scientific article published on 13 June 2019

The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma

artículo científico publicado en 2019

The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives.

artículo científico

The development of PARP as a successful target for cancer therapy

artículo científico publicado en 2017

Tubulin inhibitors in non-small cell lung cancer: looking back and forward

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda